Target intelligence / Profile preview

Qi regulation pathways

Molecular classification
Other (TCM concept, not a molecule, receptor, protein, etc.)
01

Overview

The term "Qi regulation pathways" refers to the network of physiological processes proposed by Traditional Chinese Medicine as controlling the synthesis, circulation, and function of "Qi"—a concept analogous to vital energy. These pathways incorporate endocrine, metabolic, immune, and nervous system activities. Modern research attempts to connect these TCM concepts to molecular mechanisms, such as regulation of hormone secretion, neuroactive ligand-receptor interactions, metabolic flux, calcium signaling, and immune responses. However, "Qi regulation pathways" is not a discrete molecular entity and cannot be classified as a target receptor, enzyme, or protein; it is a holistic conceptual framework encompassing multiple molecular pathways that together maintain homeostasis and health[2][1][6].

Other names
Qi pathwaysQi-regulating pathwaysQi signaling pathways
02

Mechanism of action

Regulation of hormone secretion (thyroid, estrogen, prolactin, oxytocin); Modulation of neuroactive ligand-receptor interaction pathways (e.g., serotonergic, GABAergic synapses); Immune modulation (type I IFN signaling, lymphocyte proliferation); Regulation of metabolic enzymes and pathways (bile secretion, lipid metabolism, carbohydrate metabolism); Improved circulation and vascular smooth muscle contraction.

03

Biological functions

Energy metabolismHormonal regulationImmune responseCirculationCellular stress responseSignal transductionOther (covers development, body temperature maintenance, organ function)
04

Disease associations

FatigueImmune deficiencyMenstrual disordersMetabolic syndromeOther (used in TCM syndromes, e.g., "Qi deficiency", but not defined by Western medical disease roles)
05

Safety considerations

Herbal therapy risks: unregulated herbal mixtures may have side effects, drug-herb interactions, and lack of standardized dosingLack of molecular specificity: cannot systematically predict or monitor safety as with single molecular targetsTherapeutic challenges: variable patient response, unclear mechanism, limited evidence base
06

Interacting drugs

Herbal formulations: Si Jun Zi Tang (SJZT)

4 more in the full profile.

07

Biomarkers

No specific biomarkers definedPotential: Calmodulin expression, gastrointestinal hormones (GAS, MOT), calcium signaling factors (from research on TCM syndromes)

Beyond the preview

Go deeper on Qi regulation pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qi regulation pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call